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Clinical research encounters as a focus of public engagement with 
science and research 
Abstract   
The clinical research encounter is a site of close interaction between research professionals 
and members of the public, as they jointly perform research, but is not normally considered 
as a potential site for public engagement.  In this paper we adduce theoretical and empirical 
arguments on the potential of this site for developing a novel mode of engaging publics with 
science.  Our empirical studies use qualitative methods, based primarily on interviews and 
participant observation.  We find that performing in a live experiment offers participants 
material engagement with science through embodied experience, and generates commitment 
to the research and to building close working relationships with researchers.  Researchers 
reciprocate, and acknowledge benefits from closer interactions with participants, though 
remaining partly constrained by their professional acculturation.  We argue that the potential 
of clinical research as an engagement site lies in the combination of material engagement 
and the conscious commitment by participants to making a contribution to a specific project. 
Thus the clinical research encounter offers a useful alternative mode of engagement to the 
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El encuentro de investigación clínica es un espacio de estrecha interacción entre los 
profesionales de la investigación y el público en general, ya que conjuntamente realizan una 
investigación, pero normalmente no se lo considera como un espacio potencial para el 
involucramiento público. En este artículo presentamos argumentos teóricos y empíricos sobre 
el potencial de este espacio para el desarrollo de una forma novedosa de involucrar a los 
públicos en la ciencia. Nuestros estudios empíricos utilizan métodos cualitativos, basados 
principalmente en entrevistas y observación participante. Encontramos que la participación en 
un experimento en vivo ofrece a los participantes un compromiso material con la ciencia a 
través de su experiencia corpórea, y genera un compromiso con la investigación y la 
construcción de estrechas relaciones de trabajo con los investigadores. Los investigadores 
intercambian y reconocen los beneficios de interacciones más estrechas con los participantes, 
aunque quedan parcialmente limitados por su aculturación profesional. Sostenemos que el 
potencial de la investigación clínica como espacio de compromiso radica en la combinación del 
 4 
 
involucramiento material y el compromiso consciente de los participantes de hacer una 
contribución a un proyecto específico. Por lo tanto, el encuentro de investigación clínica ofrece 
un útil modo alternativo de compromiso con el paradigma basado en el lenguaje que 
actualmente domina el trabajo en este campo. 
 
Investigación clínica, encuentros de investigación clínica, involucramiento público, 




Clinical research encounters as a focus of public engagement with 
science and research 
 
  1. Introduction 
In this paper we advance the general thesis that medical research involving humans has the 
potential to act as a site of public engagement with science and research. Our particular interest 
is in the involvement of those who enrol as participants in experimental or observational 
studies. Study of the literature suggests that this area has been overlooked by scholars and 
official bodies writing on public engagement. Yet clinical research with humans requires  
close proximity and interaction between scientists/clinical researchers and a lay public when 
they come together to perform clinical research.  
At present, activities recognised as public engagement in clinical research are generally enacted 
through the mechanism of committees that involve patients and patient advocates in strategic 
and managerial decisions.   Such activities thus take place at sites removed from the clinical 
encounter between researchers and research participants. We recognise the contribution made 
by these mechanisms, which are well established, well researched, and well-funded by national 
governments and charitable sources.  Through such mechanisms, patients and other lay people 
are involved in questions of priority-setting, design and management of research and have 
opportunities to wield strategic influence on the politics of clinical research, as well as 
involvement with specific local projects (Brereton et al., 2016; Canada:, 2000; NIHR, 2017).  
More recently there has been increasing evidence of patients taking or sharing the lead in these 
kinds of discussion (see 4.1.4 below).  Some of those involved in this strategic work may also 
be research ‘participants’, but the site of activity remains the committee room or discussion 
forum, not the place where research is done. 
In this paper we refer to how public engagement in clinical research is dominated by this kind 
of committee-based activity, to the apparent neglect of other, different, opportunities for 
clinician-researcher-public interactions.  We argue that the dominant focus on patient input at 
the strategic and managerial level need not exclude the development of other routes of 
engagement.  Clinical research with humans offers participants a lived experience of real-life 
science.  Its potential as a site for engagement lies in the combination of material engagement 
and the conscious commitment by participants to making a contribution to a specific project.  




In the next section of this paper (Section 2. Defining public engagement in clinical research) 
we define our key terms and the kind of engagement we believe can develop in the context of 
clinical research.  Section 3 (Empirical Data) summarises the evidence from our qualitative 
study of volunteers in clinical experiments and comprises three subsections on Methods, 
Participant data, and Researcher data.  The Discussion that follows (Section 4) first sets our 
claims for clinical research as a site for public engagement in the broader institutional 
environment and considers the implications of that environment for alternative developments 
in public engagement. The second part of the Discussion assesses what engagement might in 
practice be attainable in the clinical setting, and its strengths and weaknesses. Section 5 
(Conclusions) briefly summarises the arguments presented in relation to a distinctive mode of 
engagement developing within clinical research encounters.  
2. Defining public engagement in clinical research 
2.1 Use of the term public engagement 
Public engagement is a contested term among practitioners and the definitions of what 
constitutes ‘public engagement’ in the literature cover a wide range of interactions and aims.  
In these circumstances, we have found it helpful to refer to the framework  set out by  (Rowe 
& Frewer, 2005, p. 253) in their typology of public engagement mechanisms.  They define 
‘public engagement’ as the general term referring to a wide spectrum of activities.  These 
activities are classified by the information flows between publics and researchers. Three main 
types emerge, namely Communication, Consultation, and Participation (see Table 2, pp 275-
282). 
We shall argue that the type of engagement possible in clinical research encounters stands 
outside the Rowe and Frewer framework in some important ways.  One characteristic of the 
clinical situation is that it does not assume any prior commitment to engage with research 
subjects, though activists or expert patients may have been involved at earlier stages.  Those 
participating as research subjects simply take part in a research project: but they have to be 
players, not bystanders.  They are bodily engaged, and the mode of their engagement is not 
so much cerebral as material and performative. 
2.2 Defining clinical research 
While the scope of public engagement potentially includes all public policy and fields of learning, 
we limit our attention here to how it may apply to clinical research, and more particularly to 
‘live’ interactions with participants in experimental work. To develop this theme we need to 
define further what we mean by clinical research and the kind of participative public 
engagement we believe is possible.  
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2.2.1 The term ‘clinical research’ is seldom defined, with one notable exception.  Levine, 
(Levine, 2008) gives the following definition: ‘research involving human subjects that is 
designed to advance the goals of the medicine (and other health-care professions). In 
accordance with this definition we use the term clinical research to cover all forms of medical 
research involving humans. That is, it includes observational and measurement studies 
requiring no physical intervention, as well as the better known ‘clinical trials’ testing new 
therapies and practices, often under strictly controlled conditions.  This point is important for 
our work and the question of how far the type of study, as well as the type of participant 
(healthy volunteer, terminally ill patient, patients with non-life-threatening conditions, and so 
on), will influence the scope for their engagement with science. 
2.2.2   By ‘clinical research encounter’ we mean the occasion(s) when research participants 
(aka ‘research subjects’ as formerly known) interact directly with professionals conducting 
research.  This is most usually face-to-face, in the clinic or the laboratory, but some kinds of 
interaction may also take place over the telephone or through electronic media. 
2.3 The kind of participative public engagement possible: parallels with informal science 
education and lived experience 
2.3.1 Informal science education 
To characterise the range of interactions possible in clinical research encounters we needed to 
turn from the dominant interests of the academic and policy-oriented literature that focuses on 
broad issues and policies.  We found alternative approaches more relevant to our narrower 
focus in this paper in some of the scholarly work originating from a ‘museums’ or Informal 
Science Education (Bonney et al., 2009) perspective.  Davies and colleagues (S. Davies, 
McCallie, Simonsson, Lehr, & Duensing, 2009), for example, defend ‘dialogue events’ that do 
not inform policy, arguing that they create an environment for social and cultural exchange far 
removed from the much-criticised one-way information transmission or management of public 
attitudes. Such events are conducted on the principles of equality of all participants and 
symmetrical learning (though it is acknowledged that this may not always be achieved in 
practice). This suggests a format likely to be transferable to the clinical experiment.   
Other educationally - and politically - motivated work focuses on the use of communicative 
media other than dialogue, notably the experiment or object-centred experience.   A high level 
of interest in the potential of the experiment as a vehicle of public participation and engagement 
has been particularly evident in programmes undertaken in museums and science centres since 
the pioneering work of Frank Oppenheimer in establishing the Exploratorium in San Francisco 




…an environment in which people can become familiar with the details of science and 
technology and begin to gain some understanding by controlling and watching the 
behavior of laboratory apparatus and machinery (Oppenheimer, 1968) 
 
2.3.2 Lived experience 
Interactive and object-oriented forms of communication have continued to be discussed and 
developed, particularly in the context of museum and exhibition displays (Barry, 1998; 
Soderqvist, Bencard, & Mordhorst, 2009), and like the Oppenheimer concept above have 
relevance for the clinical research situation The similarities include participants doing science, 
and participation often taking a material form – interacting with measuring devices or scanning 
equipment, giving samples etc.. 
The immediacy of the lived experience of science and technology (through experiment or 
exposure to scientific objects) has been claimed to be superior as a model of communication 
to the traditionally privileged culture of interpretation via language (Gumbrecht, 2004).   This 
has resonances with other recent work ranging from renewed philosophical interest in the 
development of an ‘object-oriented ontology’ (arguing for an understanding of objects as 
entities and actants independent of human mediation) (Harman, 2007, 2011) to empirical and 
theoretical studies of the significant role of material objects in environmental engagement 
projects (Marres, 2009).  Soderqvist and colleagues (Soderqvist & Bencard, 2010; Soderqvist 
et al., 2009) argue ‘that we appropriate with our bodily faculties prior to and irrespective of 
any linguistic appropriation of the world’, and that this provides a fruitful way to explore the 
relationship between humans and objects (p.100).  Given the significance of sophisticated 
technology and specialised environments in today’s clinical research, we speculate that the 
exposure of research participants to the materialities of science could add to their knowledge 
and perceptions of science in fruitful ways.  Of interest  here is Marres’ understanding of 
‘material forms of engagement’ as a performative phenomenon, and a particular modality of 
participation, which seems likewise relevant to the research encounter (Marres, 2012).   
2.3.3 Material engagement 
A distinctive feature of the clinical research encounter is that those members of the public 
enrolled as participants are taking part in a live experiment.  Research is assimilated as a lived 
experience, and depending on the specific research, often is literally an embodied experience. 
In clinical research, as to a lesser extent in health care, the participants are likely to be brought 
into close proximity with novel equipment and practices. 
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We suggest therefore that engagement in clinical research may be mediated by that bodily 
appropriation or experience of the material paraphernalia of science discussed in the previous 
section.  The lived experience is a contributor to, and constituent part of, the relationship forged 
with science (or a particular piece of science) by people taking part in experiments.  Our 
empirical data indicates that clinical research participants react emotionally and physically to 
the sounds, smells, flashing lights and vibrations of people and equipment they encounter in 
giving their ‘live’ performance.  This has some features in common with the work on ‘shared 
immersion’ - involving lay people joining a team of professionals  to perform simulated surgery 
(Tang, Maroothynaden, Bello, & Kneebone, 2013) though there are fundamental differences in 
setting and type of relationship.   Both however constitute a different type of engagement from, 
for example, a focus group mediated almost solely through language. Further development of 
this area appears both feasible and worthwhile.  
In the next section of the paper we adduce empirical evidence about the engagements 
occurring between researchers and members of the public acting as research participants. 
While interactions through dialogue are of course present, and important, these take place 
within the framework of a performance, and a particular material environment.  We have called 
this ‘material public engagement’ but it might equally be described as ‘public engagement as 
public performance’ – a phrase kindly brought to our attention by an anonymous referee, to 
whom we offer thanks. 
3. Empirical data 
In the absence of any definitive indicators from the literature on the potential of routine clinical 
research as a site for public engagement, we decided to undertake a secondary analysis of 
data collected for a broader empirical study of participant experience of research on a new 
health technology.  This ESRC-funded study aimed to gauge the scope for research participants 
- in the course of a biomedical experiment led by scientists - to engage as a public with the 
science they encounter and with the staff involved.  As with most clinical research the lay 
participants had no prior input to study design and planning.  Thus we were a long way away 
from ‘participative research’, since conventional power structures remained unchanged. This 
did not however necessarily inhibit participants from seizing their window of opportunity to 
influence the action (as noted by Davies (S. R. Davies, 2013) in a different context). 
3.1 Methods 
The biomedical study forming the site for our research was non-therapeutic and low risk.  It 
concerned the first tests in humans of a new high-tech optics-based diagnostic technology with 
potential for application in early recognition of breast disease.   It offered no hope of direct 
medical benefit to the participants, who included healthy volunteers as well as women with 
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benign or cancerous breast conditions.  Participants were normally seen only once by the 
research team.    
The social scientists (including two of the present authors) worked in collaboration with a team 
of UK medical physicists about to start in-vivo clinical testing of their prototype imaging system. 
We added to the original test protocol to allow collection of feedback and views on their 
experiences from test subjects. The data would be used to help in development of the 
instrument and test procedures and to explore the feasibility of engaging participants in 
discussion about issues addressed or raised by the research.  Separate ethical approval was 
obtained for the social science arm of the study. The qualitative methods used comprised 
observation of test scans, and in-depth interviews with participants and researchers by two 
experienced sociologists. The same methods were later used for a smaller study in the USA 
where tests of a related optical technology, developed by another team, were in progress.  
Observations and interviews were carried out with 65 women in the UK, and a further 15 in the 
USA.  Participants for both sites were recruited by collaborating clinicians (for patients) and 
personal or institutional networks (healthy volunteers). All interviews, and scan sessions when 
feasible, were audio-recorded and transcribed verbatim. Analysis was by standard sociological 
methods, with assistance from N-vivo software for coding, analysis and data management.  In 
this paper individual participants are identified by a code specifying their location (UK or US), 
their cohort (I or II) where applicable, their status as patient (PV) or healthy volunteer (HV) 
and an individual number. We also conducted a total of 12 interviews with 10 different 
researchers, as a necessary complement to the participant data, and held informal group 
discussions with the research teams.  In addition we took part as observers or participant-
observers in many of the experimental sessions so could observe interactions at first hand.  
Researchers are identified by a code that consists of the country in which they are located (UK, 
US, or NL) and a number. 
The project was not selected as being representative of a major tranche of clinical research but 
chosen for its simplicity.  Being non-therapeutic it avoided the difficulties of exploring research 
participation when the line between research and treatment (normal care) is blurred (Whong-
Barr & Haimes, 2004)  In such circumstances patients may feel driven to join the study as ‘a 
lifeline’ (Agrawal et al., 2006), or choose participation as offering them a superior standard of 
health care (McCann, Campbell, & Entwistle, 2013; Timmermans & McKay, 2009; Townsend & 
Cox, 2013).  Nor was the study a randomised, controlled clinical trial (RCT).  Though we are 
aware that the RCT is often taken as the epitome or ‘gold standard’ of clinical studies, it has a 
number of structural disadvantages for studying the scope for more active participation. These 
include the relatively inflexible structure (particularly of multi-site trials) and inherent ethical 
issues (for example, around understandings of randomisation and equipoise).  
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In reporting our findings, we accept that the expectations and priorities of patients enrolled in 
a therapeutic clinical drug trial are likely to be different from those in our study (Catt, Langridge, 
Fallowfield, Talbot, & Jenkins, 2011; Locock & Smith, 2011).  The interests of paid ‘professional 
guinea-pigs’ (Almeida, Azevedo, Nunes, Vaz-da-Silva, & Soares-da-Silva, 2007; Weinstein, 
2001) would be different again.  Nevertheless, some of the issues addressed by participants - 
and which seem to drive them to engage - appear to be generic to clinical research 
participation: namely, resisting or re-defining the ‘guinea-pig’ label; dealing with intimidating 
surroundings; dealing with social challenges like being undressed in front of strangers; 
uncertainty about what is going to happen; being patronised; and fulfilling their personal need 
to perform creditably (Goffman, 1971). 
3.2 Findings: Participants 
3.2.1 Feasibility 
Participants in the biomedical study were highly cooperative regarding participation in our 
qualitative study.  It seemed to generate satisfaction that they were not being regarded as ‘just 
bodies’, but asked to comment on their experience (see ‘guinea pigs’ below).  The collaborating 
researchers too were positive, reporting positive effects on their work and relations with the 
participants.  We interpret this as ‘soft’ evidence of a general willingness to engage beyond the 
limits of the formally defined research project, and to enter into a closer working relationship 
between lay participants and researchers.  
3.2.2 Sensational science: entry to a hidden world 
In his critique of dialogue-based communications, Irwin (Irwin, 2008) concludes that something 
more may be needed (probably still with dialogue in mind): ‘‘forms of communication that do 
not simply trade in the unreflexive language of deficit and dialogue, but that open up fresh 
interconnections” (p.225).  Indeed, participants’ accounts suggest that, for them, engagement 
was less about dialogue or technical content, but experience of an embodied or material 
engagement.  Accepting an invitation to participate in an experiment seems to have an element 
of ‘sensation-seeking’ in the popular sense, like a traveller venturing into a foreign culture. 
Participants often appeared to relish the opportunity of a novel experience and visiting behind 
the scenes (this is not dissimilar to reported reactions of visitors to a science festival (Jensen 
& Buckley, 2014)).  Even those with some scientific background expressed fascination in 
viewing the work from a different, ‘research subject’ perspective, which, in the words of two 
different interviewees, made the experience ‘strange’ or ‘surreal’.   While for some, reactions 
were dominated by personal background (for example, recent medical history), many 
expressed curiosity about this largely hidden world or commented on the mental or physical 
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sensation they felt there: ‘I was in there among the engineers’ (UKIPV8): or ‘To see what they 
are doing, and have a chat with them, and feel that energy’ (UKIPV15).  
In some cases, entry into the physical world of the study as participants was a visible (though 
transient) surprise.  For example, one healthy volunteer on entry to the laboratory where the 
experimental scan would take place exclaimed: ‘Wow! It’s like Frankenstein’s lab’ (UKIIHV5).  
Or, as another participant, a patient, tells it: 
…all of a sudden, there’s this lab, gosh, this really is a lab. .. I suppose that when you, when 
you come in, you actually see, my goodness, this really is an experiment.  (UKIIPV33) 
This mixture of practical, emotional and self-mocking reaction on being exposed to the material 
world of science demonstrates its impact on the participants, and how they shape or reshape 
their behaviour and opinions to make themselves at ease with these phenomena.  It seems 
thereby to constitute a key point where understandings of science might likewise be shaped, 
and an opportunity for scientists and lay participants to collaborate in that process.   As we 
now discuss, this general notion of ‘sensational’ science appears to frame a range of more 
specific types of engagement that, far from being abstract, cerebral or dialogic, are instead 
material and embodied.  
3.2.3 Participants reconstructing themselves for engagement 
Managing personal fears and aspirations.  As volunteers, participants in our study first had to 
organise themselves and construct identities to help them deal with the often novel, always 
unscripted, situation of being a research participant (Goffman, 1971; Morris & Balmer, 2006).  
Though this is likely to be a process all participants have to go through irrespective of any 
engagement agenda, its shape and articulation may depend on interactions with researchers, 
as rationales and self-image are stimulated by context and others’ expectations (Mills, 1940).  
One key task for our participants was confronting the guinea-pig stigma.  Some participants 
professed a breezy acceptance of the passive role of guinea pig with such comments as: ‘we 
are just bodies basically’   (UKIIHV4): or ‘I’m just someone who’s willing to, to be a guinea pig 
for helping people carry out research.  It’s nothing special’’ (UKIIPV10). 
But, there was evidence of underlying reservations.  The second participant quoted above later 
revealed some of the tensions inherent in the guinea pig role: 
Like I can express my feelings afterwards [in the interview] and it’s not just like, oh, I’m this 
guinea pig and that’s, that’s it, I’m just used and then off I go.  You can actually attempt to 
contribute something which might be helpful.  (UKIIPV10). 
Thus not only was the reassurance of being treated like a thinking human appreciated, but so 
was the perceived opportunity to open up her role and become an active contributor.  Good 
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researcher-participant relations are needed to provide reassurance regarding ‘guinea-pig’ 
apprehensions, and constitute an essential baseline condition for further engagement: as one 
of the US participants commented: 
I felt very special.  .. I don’t feel like a guinea pig, a little rat or anything… You just, I just felt 
really welcomed, you know, and real special for doing this (USHV296). 
Defining a role and focus. Participants often mentioned ‘curiosity about the research’ as one of 
their motivations for participation (Almeida et al., 2007; Locock & Smith, 2011).  We noted that 
for some participants the interest stayed at a generalised, quite abstract level: ‘Interesting ... 
the idea of future developments from that research … it makes me happy that I’ve been part 
of it’ (UKIIPV2). Whereas others wanted to explore the technicalities of how it is done: ‘I’m not 
a medical person at all but I can understand the concept – I’m interested … in how they graph 
it out’ (US288) 
I wish that there was a way that you could (…) have some kind of explanation as to what each 
of those light frequencies would mean, what kind of tissue they’re really looking at, you know. 
(USHV278).  
Others might question the researchers about potential further applications, for instance: ‘Can 
you use it on men’s bits?’ - (UKIPV2) 
This curiosity, like that of an interested guest, was thus quite a relaxed affair, but appeared to 
add to overall satisfaction.  Going beyond that however, other participants - perhaps driven by 
the exigencies of the interview situation (Callon & Rabeharisoa, 2003) – were more inclined to 
articulate a vision of themselves as partners in knowledge creation and translation to practice.  
They might see their body as being the informant: ‘I’ve got three, three different areas of 
infection [in the breast] … So I would say that I would be a good candidate for seeing if this 
machine works’   (UKIIPV3).  Others claimed a status for themselves within the research team 
as active contributors: ‘I suppose it’s I see myself as kind of helping move on breast imaging’ 
(UKIIPV4): ‘I felt I was part of the team’ (UKIHV2); or ‘[we are] pioneers, not victims’ 
(UKIIPV1). 
Another participant – a woman with active breast cancer – highlighted the significance for her 
of not being a patient in this context.  She was not a supplicant, but a donor: It’s not like going 
to a medical appointment, because it’s research. ... You want something from me more than I 
want something from you.  That’s the point.  (UKIPV16). 
Status was important.   It was acceptable to be a ‘data point’, ‘a statistic‘, on the understanding 
that they were nonetheless both individually and collectively essential to the R&D process, as 
the following quotations indicate: 
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If you don’t have people like myself you can’t move forward. …You need volunteers: without 
volunteers you can’t progress (UKIIPV5) 
You obviously need to have people to try this thing out on … I mean it would just be theory 
unless you could actually try it out on somebody (UKIIPV19) 
You need to get the numbers up, the ‘n’ equal number up so, again, and as a scientist, you 
know, you gotta do the epidemiology. ….. Everyone counts. (USHV2) 
To adapt a phrase from Michael, the participants are actively engaging themselves in ‘doing 
being a research participant’ (Michael, 2009).  This may constitute a necessary preliminary 
before progressing to the more sophisticated and self-conscious participation that Michael 
describes, where lay participants in public engagement develop and redefine their role over the 
course of an engagement exercise, and which he calls:  ‘doing being a member of the public’. 
3.2.4 Engaging with the material processes of science 
Physical contact with the instrumentation and exposure to a research environment were 
integral to these participants’ task [see Figures 1 and 2]. The confrontation with the material 
culture of science and ‘science-in-the-making’ was a completely novel experience for some, but 
they took on the challenge of shaping their relationship to it.  We identified a number of facets 
to this embodied engagement. 
Figure 1. Diagrammatic view of scanning bed 
 









 First, making the experiment work by doing it right, not ‘messing up’:  
…at first I was like, oh no, I’m moving too much because I can feel myself breathing and I’m, 
you know, mortified I’m going to mess up because I’m breathing too fast or too heavily.  
(UKIIPV10) 
I was worried before I came, that I would start coughing, which I did, and would spoil it.  
(UKIPV12). 
The participants here identified themselves with the research endeavour, and with playing a 
small, but crucial, role in the experimental procedure.  They took pride in, and avoided damage 
to self-esteem by giving a good performance.  
Secondly, appropriating and demystifying the technology, for example, by taking the initiative, 
to ensure they were optimally positioned for the scan (e.g. breast fully in the coupling liquid): 
Researcher:  So, I’ll turn the lights off now 
PV: I don’t feel I’m completely in.  Is that as high as it [the liquid] goes? 
Researcher:  Um, I’ll top the liquid up a bit 
PV: Well, yeah, because it’s - can you see? There’s sort of an inch not […] [Researcher: yeah] I 
think I’ll just move [the pillow]   (UKIIPV37) 
 
In this instance the participant was rewriting the rules, and enlarging her role, by temporarily 
taking over the management of a detail of the project from the researcher, albeit with due 
deference.  She was also demonstrating that she felt at ease with the technology. 
A further common participant strategy to demonstrate or bolster their ease with the ‘props’ of 
science (Oppenheimer, 1968), and thus work on equalising the relationship with the researcher, 
was through humour.  Participants domesticated the technology by means of down-to-earth 
analogies.   Thus the inset, liquid-filled bowl into which the breast had to be lowered for 
imaging, provoked comments of ‘You gotta put it in a bucket?’ (UKIIPV39) or ‘That looks like a 
loo, doesn’t it?’ (UKIIPV30).  Likewise the rather cluttered laboratory provoked jokey comments 
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of the kind ‘it looks like my living room’.  As well as being part of negotiating an easy relationship 
with the researchers, and enjoying a kind of ‘backstage chat’ with them (Goffman, 1971, p. 
114), this also helped adjustment to a strange environment. 
Thus the comments and behaviour of the research participants show them as committed to 
performing their research role to the best of their ability and engaging both physically and 
mentally with the technology and the research environment. Overall, we see them working to 
create a secure platform from which they can build a more active engagement with the 
researchers and with those aspects of the research they feel are within their grasp.  How far 
they can take this nevertheless depends a great deal on the receptiveness of the research 
team. 
 
3.3 Findings: Researchers 
3.3.1 Researcher priorities 
The researchers’ approach to the research encounter operated on a different scale from that 
of participants.  They were focused on their project as a whole; comprising many experiments 
and many participants as well as ongoing analytical, computing and engineering development.  
Participants were normally involved only for a couple of hours so their attention was on the 
single experiment and how they performed or reacted to it.  For some researchers interacting 
with participants was a new task to assimilate, for example: 
I’m saying this completely in terms of physical, almost thinking about these volunteers as a piece 
of instrumentation I suppose (UK2) 
The most important thing for us is the quality of the data. …Having said that if people come to 
us we want them to be comfortable and we’re going to get better quality data if they are 
comfortable (UK1). 
Researcher anxieties, as well as the expectation of practical benefits voiced above, acted as an 
incentive to interactions with participants.  Non-clinical scientists not accustomed to dealing 
with human participants acknowledged anxieties about finding the right approach and whether 
their technology was sufficiently optimised for the purpose.  Talking and listening to participants 
provided reassurance, as explained by two researchers from different research environments: 
So I think we can always keep on, you know, listening … … you never know, someone might 
mention something that you haven’t thought about (UK3) 
I don’t know, maybe we just forget about something, something important. We cannot finish; 
we are learning always (NL2). 
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3.3.2 Professional distance 
A further incentive to interactive dialogue was researchers’ concern about discharging the 
responsibility they felt for ensuring that participants were sufficiently informed about 
technicalities to give a valid consent.  The ethical and technical talk that took place during scan 
sessions (reported on in Morris, et al (2009)) fulfilled these purposes and also served other 
ends, such as reassuring participants on safety and establishing their own professional standing 
and experience. 
The researchers’ traditional understanding of their professional responsibilities includes always 
being in charge and being protective of participants.  Their role (as formulated in codes of 
ethics) comprises leadership, and giving reassurance to the vulnerable (P. Weindling, 2001; 
WMA, 2013). In the research encounter, as when dealing with the public generally they felt, as 
one said, a responsibility to be ‘an ambassador for science’. The effects of this culture tended 
to maintain a certain professional distance between themselves and participants. This has 
implications for engagement when engagement should be on equal terms.  They nonetheless 
appreciated the benefits of a good and cooperative working relationship with participants, 
because it not only served their instrumental ends but also engendered mutual satisfaction – 
as shown in the following quotation from the lead UK researcher: ‘The perfect patient would 
be one that did everything I asked them.  But at the same time gave me complete feedback 
the whole time about how it was going’ (UK1). 
3.3.3 Asymmetrical relations 
Asymmetries in the relationship nevertheless remained: for example receptiveness to input 
from participants was generally limited to matters of physical comfort, and action on 
participants’ suggestions confined to short-term, low-cost re-arrangement and amelioration.  
Participant comments on possibilities for re-design were unlikely to get serious discussion 
because these were seen as  ‘outweighed by technical considerations ‘ (UK4),  and therefore 
viewed as exclusively the province of the research team: 
We do everything that we can immediately that’s pretty quick and … more for comfort … Whereas 
the more technical side is more geared towards what we’re trying to do ourselves (UK4). 
Discussion was likewise ruled out on the issue of the uses to which the technology might be 
put. Participants were strongly in favour of its eventually replacing the mammogram, but all 
the research teams ruled this out as self-evidently not feasible (in terms of costs and vested 
interests), and not a matter for discussion with participants.  This closed off a potential avenue 
to discussion of public policy, science politics and science-society relations. Such discussion 
would not of course help to progress the immediate research project, which was always the 
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researchers’ main focus. With regard to involving participants in decision-making the situation 
is a little more fluid. On the one hand both the EU researchers interviewed initially asked for 
clarification of ‘decision-making’ and then did not engage with the issue: 
I really don’t [worry] about it [the fact that the breast needs to be slightly compressed] because 
I am sure it is going to be really gentle. .. You need to compress breast only to have good 
contact. … This I think will be no problem at all (NL2). 
On the other hand, another researcher said he was open to the idea of discussing strategies 
but nonetheless could not see a way forward: he commented that participants were involved: 
… on a very short term basis ….On the longer term basis, the strategic basis, in terms of how 
we redesign our system, perhaps kind of passively.  [Pause]  In fact, that’s a difficult one.  I 
would like to think that they were involved but I really don’t know how (UK2). 
Basically the position is to leave the technical decisions to the technical people.  The borders 
of the technical and the techno-social are shifting but working cultures may be slower to change 
- see (Caron-Flinterman, Broerse, & Bunders, 2005) for parallels.  
 
4. Discussion 
In the preceding sections we have set out the basis from which we see the clinical research 
encounter developing its capacity to foster ‘engagement’, i.e. developing a mutual 
understanding between ‘publics’ and scientists about matters of science and research.  Such 
an understanding could have ramifications beyond completion of the immediate task.  We shall 
go on to explore further how such beginnings might be developed (section 4.2).  Before that 
however we need to take stock of the academic and socio-political institutional environment in 
which this new development must grow, and how elements there may help or hinder such 
development. 
4.1 Institutional environment 
4.1.1 Public engagement policy 
Governments’ policies for advocating and funding public engagement generally give 
prominence to encouraging dialogue between citizens and government to increase mutual 
understanding.  Thereby they hope to exert a positive influence on public attitudes to national 
policies for change and innovation (EuropeanCommission, 2013; House-of-Lords:, 2000; 
Zerhouni, 2003).   Likewise the public engagement literature has ranged widely over issues of 
the democratisation of scientific decision-making, scientific citizenship and power structures 
along with critical discussion of engagement mechanisms and policy dialogue (Elam & 
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Bertilsson, 2003; Irwin, 2001; Irwin, Jensen, & Jones, 2013; Laurent, 2011; Lehoux, Daudelin, 
& Abelson, 2012; Lengwiler, 2008; Rowe & Frewer, 2005; Stirling, 2008).  Particular criticism 
has been levelled at the take-up and execution of ‘dialogue’ by scientific and political institutions 
(Powell & Colin, 2008; Stilgoe, Lock, & Wilsdon, 2014; Stirling, 2008; Wynne, 2006). Critics 
claim that much of the policy drive for this work has been based on ‘imaginary publics’, 
supposedly anti-science, low trust etc. The processes themselves may be viewed as a means 
to manage these and/or create new informed and attitudinally correct publics (Gregory & Lock, 
2008; Stilgoe et al., 2014).  This critical vein we read as indicating a continuing need for 
developing variant forms of engagement. Such variants might enable some gentle loosening of 
the power structures that limit exchanges between ‘publics’ and policy practitioners, giving 
mutual benefits.  
4.1.2 Public engagement with clinical research 
Here policy focuses on promoting dialogue to help formulate policies for health and well-being, 
both generally and in relation to particular projects.  In the UK (where most of our own research 
has been done), the close coupling of clinical research with health care, due to the National 
Health Service (NHS), has influenced the way the institutions of public engagement have 
developed.   Thus the government-funded institutions set up within the NHS to foster public 
engagement (the Public and Patient Involvement initiative (PPI)) have a strong focus on patient 
care (research being blended into care). They typically work through committee structures 
modelled on those for health-care delivery.   Consequently public engagement in medical 
research becomes conceptualised as an activity taking place quite separately from the research 
encounter.   
The locus for public participation in clinical research is thus the committee room - within a 
management board or advisory panel - not in the laboratory or clinic. Similar practices may be 
observed in studies of Patient Associations working to strengthen the patient voice 
(Rabeharisoa, Moreira, & Akrich, 2014).  Such interactions are important, but need not preclude 
developing a complementary stream of work at the site of the experiment or intervention, 
where research participants and front-line research scientists/health professionals regularly 
meet and interact.  
4.1.3 Institutional rulings on clinical codes of practice and ethics 
Our focus on participant-researcher interactions raises the question whether, given current 
conventions governing clinical research practice, research participants can rightly be regarded 
as a ‘public’ for engagement.  Participants are often also patients and may participate in 
research primarily for expected health care benefits (Agrawal et al., 2006; Easter, Henderson, 
Davis, Churchill, & King, 2006; Locock & Smith, 2011; Timmermans & McKay, 2009). As 
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discussed earlier, matters are further complicated where a terminally ill patient views 
volunteering as a last resort treatment, though this can sometimes lead to an ultimately 
productive public engagement (Epstein, 1996). Furthermore, where doctor and researcher are 
the same person, distinctions between the doctor’s and the researcher’s obligations may 
likewise be blurred, presenting difficult practical and ethical dilemmas (Abma, Nierse, & 
Widdershoven, 2009; Fisher, 2008; Sariola & Simpson, 2011; Timmermans, 2011).  
Current codes of medical ethics are the prime influences in framing research participants’ 
identities.  These codes reflect their origin in the abuses revealed in the Nuremberg trials 
(Moreno, 2001; P. J. Weindling, 2004) and within a then largely paternalistic medical 
profession.  As a consequence, despite regular revisions, internationally agreed ethical 
frameworks still enshrine a perception of the research participant as essentially passive and 
vulnerable. Though still a valuable safeguard, arguably and with some exceptions the current 
framework accords less well with the totality of today’s better informed, better protected and 
organised patients and volunteers, at least in industrialised countries (Cooper, 2012; Moreira 
& Palladino, 2005; Weinstein, 2001).  In the UK recent activity by the Health Research Authority 
which governs research on NHS staff and patients indicates a greater openness to the 
capabilities of patients and research participants.  Thus what could have been a hindrance to 
development of engagement within the clinical research encounter may lighten in the future. 
4.1.4 Where next? 
Although there is an extensive body of work in both the social science and the medical 
literatures about research participants, we have not as yet found studies that consider 
possibilities for lay public engagement with science as an ancillary or complement to their 
participation in the research. That said, Epstein’s seminal study of AIDS activists and the politics 
of knowledge did demonstrate how the experiences of the activists, many as research 
participants, had epistemic effects on the design of clinical trials and the regulatory process 
(Epstein, 1996). There is also a significant literature on emergent health movements and 
patient associations’ involvement in promoting and prioritising research in their field of interest 
(Brown et al., 2004; Callon & Rabeharisoa, 2008; Panofsky, 2011; Rabeharisoa et al., 2014). 
These activities illustrate new ways of effecting strategic engagement with policy, often 
facilitated by new developments in information technology. 
In summary, the current institutional environment, while not intrinsically hostile to the 
development of another stream of public engagement with clinical research, is deeply pre-
occupied with other modes of engagement. These modes are policy-oriented, dialogue-based, 
and promote public involvement in management-type decisions.  It would be over-optimistic to 
 21 
 
expect much support for novelty from these settled institutions, unless the new strengths given 
to activism by developments in information technology stimulate some re-thinking.   
4.2 What kind of engagement may be developed in the clinical research encounter? 
4.2.1 What kind of partnership? 
While both researchers and participants in our study engaged with each other to help in building 
a good working relationship, they had different conceptions of how far this might constitute a 
partnership.  For participants a temporary recognition of them as team members and a will to 
engage with the scientific objectives of the research could enable them to feel socially 
comfortable in a strange situation, to feel enriched by new experiences and satisfied with their 
contribution.  As the empirical data shows, they achieved this endpoint in a variety of ways - 
often tentative, experimental and instinctive.  
As already pointed out, researchers’ interactions with participants can be constrained by 
demarcation of the scientist-researcher role and traditional expectations about passive patient-
participants. They committed to listening and responding thoughtfully to conversational 
overtures, knowing this was good for both participants and research, but were selective about 
which issues raised by participants they engaged with - a situation these participants appeared 
to accept.  It could be a relatively easy step towards a more serious engagement to lift this 
embargo on discussion in the expectation more of increasing mutual understanding rather than 
changing views. 
We acknowledge that we are using the terms ‘engage’ and ‘engagement’ loosely in applying 
them to the drive shown by participants in the empirical studies to involve themselves in the 
aims of the research and to make themselves useful contributors to the outcomes.  Our 
commentary may demonstrate that both participants and researchers are working actively to 
build a social relationship, but where (apart from the small step towards opening up broader 
issues identified above) is the link to ‘public engagement’?  How far may these overtures and 
relationships act as a foundation for a rapprochement between science (or scientific research) 
and a lay public, and what purpose would this serve?  
4.2.2 Engagement in practice 
We suggest that the potential of clinical research as an engagement site lies in the combination 
of material engagement and the conscious commitment by participants to making a 




It is characteristic of the clinical research encounter that the interaction is mainly about the 
here and now - the experience and outcome of being part of research in a particular context 
rather than engagement with broader issues.  The primary goal of the participants, as of the 
researchers, is successfully to complete a particular clinical study: public engagement or 
dialogue is a spin-off, not a driver. Participants are in a ‘work experience’ situation where their 
contribution matters and where they are necessarily exposed to ‘science-in-the-making’ and 
are taking part in real-life, real-time research with its full share of failures, glitches and 
uncertainty of outcome.  Participants engaging in this way showed readiness to recognise the 
opportunity and privilege of temporary admittance to the research world (Parsons, 1969). In 
addition, implicitly or explicitly, they strive for a more equal partnership. In engaging with the 
research topic and process, the researchers and the technology, they were observed drawing 
on their own resources (their own experience and interests) to configure themselves to be part 
of the enterprise, each in their own way (Morris and Balmer, 2006: Morris et al, 2009).   
This has similarities to what Michael (2009) refers to as ‘doing being a member of the public’.   
People taking part in research are also ‘making themselves up’ (Hacking, 2004) by taking on, 
and socialising, a new or unusual experience.  They are taking up roles and identities to manage 
their social encounters (Goffman, 1971).  Adding opportunities for them to contribute to 
shaping the research (and the policy questions it raises) gives scope for making oneself up as 
a citizen or user or taking some early steps in that direction.  Hacking refers to this as the 
‘bottom-up’ process that combines with the ‘top-down’ institutional and governmental 
structures that constrain and enable the making up of each individual. So, in this respect, 
participants are not simply the altruistic, ‘gift-giving’ collaborators identified by Parsons and 
Mead (Mead, 1969), but may be performing a number of identities simultaneously.  While we 
do not regard this broader social dimension as a condition for the existence of ‘engagement’ 
with science, such a development would fit well with the movement among some patient 
leaders and activists to perform a more strategic role in research and health care matters 
(Morris, Balmer, & Hebden, 2011).  
4.2.3 Constraints and opportunities   
Clinical research sites of course have limitations with regard to serving any wider purposes. 
Neither ‘clinical studies’ nor ‘research participants’ are a homogenous group.  Flexibility to 
amend or make space in a study protocol for participant input and reflections varies with types 
of study, participant and sponsor.  Studies range from academic exploratory to multi-site clinical 
trials.   Participants comprise patients and healthy volunteers looking for very different rewards. 
Whether a trial is commercially or public-sector sponsored is also relevant since commercial 
organisations are not constrained in the same way as public-funded bodies to demonstrate 
compliance with national policies for public engagement with research.  There are however 
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examples demonstrating at least the possibility of flexibility in designing multi-site, international 
clinical trials to incorporate participant views - though not with public engagement in mind 
(Donovan et al., 2002; Nyanzi-Wakholi et al., 2009). 
Impediments may sometimes be turned into opportunities.  As we have already noted 
participants may choose to engage with research and researchers as quasi-collaborators for 
their own purposes.  In so doing they may run ahead of the researchers, who appear to be 
more inhibited about entering collaborative territory.  Our interviews with researchers suggest 
that for them ‘collaboration’ implies a more equal relationship than the traditional medical-
ethical framing of the research subject would readily allow, and so carry the risk of putting 
them in dereliction of their professional responsibility to protect vulnerable subjects.   This 
permits (though does not guarantee) a situation in practice where any engagement agenda 
within clinical experiments can be largely at the discretion of the participants.  If the effort of 
building an interactive, social, working relationship is undertaken largely by the participants, 
the degree and style of engagement may be likewise at their discretion.  On arrival at the 
experimental site, it is up to the participant whether to adopt the role of passive subject, quasi-
patient or active (‘engaged’) participant, or shift between such roles (Morris & Balmer, 2006).  
Thus though the overall design and conduct of the experiment may be entirely researcher-
controlled, within this envelope development of the engagement agenda might yet be 
participant-led.  
5. Conclusions 
Our opening questions were about what potential there might be for clinical research (research 
involving humans) to add to the public engagement repertoire, making use of the clinical 
research encounter where researchers and lay participants are necessarily brought into close 
proximity to work together on a common task. We have argued, both theoretically and 
empirically, for recognising this potential.  Of course, the extent of influence and effects of such 
public engagement remain a matter for further empirical enquiry. 
5.1 Governance, history and active participation 
We noted that the current institutions fostering public engagement in clinical research draw 
public and patients into strategic and managerial activities, and are necessarily dialogue-based. 
An apparent lack of interest in considering research participants as a public may follow from 
the way the governance of clinical research has been shaped by traditional bioethical 
assumptions and historical legacy. That is to say, by the model of the passive, vulnerable 
subject, and by fears of abuse.  A further reason may be the practical circumstances pertaining 
in much of clinical research (as alluded to in the latter paragraphs of 3.1 Methods).  Our 
empirical studies of research participants however suggest that at least some are ready to take 
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on a more active role than traditionally assumed.  Their narratives and asides demonstrate how 
active participation can be important to them as a means of managing the social stresses of 
the research encounter by establishing themselves as partners or quasi-collaborators in the 
research.  Interviews with researchers likewise showed they found benefit for themselves in 
dealing with the tensions of their role and benefits for their research in achieving a mutually 
supportive working relationship.  
5.2 Potential forms of engagement     
Along with other sites for engagement the clinical research encounter offers the opportunity to 
influence local decision-making, with possibilities for tangible results.  Research protocols may 
be tweaked or revised to take account of participant feedback; researchers may become more 
conscious of the emotional needs of volunteers.  Such local paybacks need not be dismisses as 
trivial, and may have ramifications beyond the immediate research project.  At the same time 
it offers opportunities for participants and researchers to work in partnership, addressing both 
user and research issues relevant to the project or beyond, including  such generic issues as 
user and researcher anxiety, ethics, participant retention, and data quality. This implies a re-
examination and possible renegotiation of taken-for-granted boundaries between ‘research 
participant’ (lay public) and ‘expert researcher’ roles in the experiment. Such a democratisation 
of researcher-participant relations is an aim shared with PPI and similar schemes, and is likely 
to be welcomed by research participants and patient advocacy groups alike.  Like the two-way 
educational activities discussed in the public engagement literature, it can at best be a creative 
experience from which something new emerges for all taking part.   
Most significantly, as we have argued, the special potential of clinical research as an 
engagement site lies in the combination of material engagement and the conscious 
commitment by participants to making a contribution to a specific project.  Clinical research 
encounters are a site of knowledge production and offer participants the special facility of 
‘learning by doing’. The participants’ material (bodily) involvement in performing research may 
not at first sight count as engagement in its own right, but the performance element generates 
a need to perform creditably and to forge comfortable working relationships with researchers.  
The combination of social and material engagement creates a potential platform for engaging 
the mind – and a resource for ‘making themselves up’ as thinking participants and as citizens 
or users through a bottom-up process.  
We opened our paper by situating it in the context of the framework of the typology of public 
engagement mechanisms established by Rowe and Frewer (2009).  While our first reaction was 
to think it would fit as an addition to the “Participation’ category, on further consideration we 
revised this view. The kind of engagement we have described is mediated by the lived 
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experience of performing in a scientific experiment, whereas the other kinds of engagement in 
the Rowe and Frewer typology rely predominantly on language and exchange (or one-way 
communication) of ideas in boardroom, committee, or special engagement event.  In the light 
of this difference we suggest it might more appropriately constitute a fourth category. If 
developed, this form of material and performative engagement might take a place as an 
alternative or complement to the engagement-as-language paradigm and lead to a revision of 
what is frequently meant by public engagement.   
We acknowledge that situations exist where social and structural conditions under which 
participants are recruited make any consideration of engagement (as we understand it) 
unlikely.  Such situations would include the social and economic structures described by Fisher 
in the United States (Fisher, 2008), or Sunder Rajan in India (Rajan, 2005, 2006).  Overall, 
however we have suggested that there is a public-in-waiting for a special modality of public 
engagement via the clinical encounter, performing a niche function in a distinctive style, and 
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